What Are the Current Strategies for Mitigating Nanoparticle-Induced Organ Damage?
Several strategies are being explored to mitigate the risks associated with nanoparticles:
Surface Modification: Altering the surface properties of nanoparticles to reduce toxicity and improve biocompatibility. Encapsulation: Encasing nanoparticles in biocompatible materials to prevent direct interaction with tissues. Targeted Delivery: Engineering nanoparticles to specifically target diseased tissues, minimizing exposure to healthy organs. Pharmacokinetics: Understanding and optimizing the distribution, metabolism, and excretion of nanoparticles to reduce organ accumulation.
